151 related articles for article (PubMed ID: 33632876)
21. Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivo.
Bernal-Chico A; Canedo M; Manterola A; Victoria Sánchez-Gómez M; Pérez-Samartín A; Rodríguez-Puertas R; Matute C; Mato S
Glia; 2015 Jan; 63(1):163-76. PubMed ID: 25130621
[TBL] [Abstract][Full Text] [Related]
22. Monoacylglycerol Lipase Inhibition Using JZL184 Attenuates Paw Inflammation and Functional Deficits in a Mouse Model of Inflammatory Arthritis.
Nass SR; Steele FF; Ware TB; Libby AH; Hsu KL; Kinsey SG
Cannabis Cannabinoid Res; 2021 Jun; 6(3):233-241. PubMed ID: 34042520
[No Abstract] [Full Text] [Related]
23. Combined inhibition of monoacylglycerol lipase and cyclooxygenases synergistically reduces neuropathic pain in mice.
Crowe MS; Leishman E; Banks ML; Gujjar R; Mahadevan A; Bradshaw HB; Kinsey SG
Br J Pharmacol; 2015 Apr; 172(7):1700-12. PubMed ID: 25393148
[TBL] [Abstract][Full Text] [Related]
24. The effects of fatty acid amide hydrolase and monoacylglycerol lipase inhibitor treatments on lipopolysaccharide-induced airway inflammation in mice.
Abohalaka R; Bozkurt TE; Nemutlu E; Onder SC; Sahin-Erdemli I
Pulm Pharmacol Ther; 2020 Jun; 62():101920. PubMed ID: 32416152
[TBL] [Abstract][Full Text] [Related]
25. Effect of monoacylglycerol lipase inhibition on intestinal permeability in chronic stress model.
Wang J; Zhang X; Yang C; Zhao S
Biochem Biophys Res Commun; 2020 May; 525(4):962-967. PubMed ID: 32173532
[TBL] [Abstract][Full Text] [Related]
26. Monoacylglycerol lipase controls endocannabinoid and eicosanoid signaling and hepatic injury in mice.
Cao Z; Mulvihill MM; Mukhopadhyay P; Xu H; Erdélyi K; Hao E; Holovac E; Haskó G; Cravatt BF; Nomura DK; Pacher P
Gastroenterology; 2013 Apr; 144(4):808-817.e15. PubMed ID: 23295443
[TBL] [Abstract][Full Text] [Related]
27. Prolonged monoacylglycerol lipase blockade causes equivalent cannabinoid receptor type 1 receptor-mediated adaptations in fatty acid amide hydrolase wild-type and knockout mice.
Schlosburg JE; Kinsey SG; Ignatowska-Jankowska B; Ramesh D; Abdullah RA; Tao Q; Booker L; Long JZ; Selley DE; Cravatt BF; Lichtman AH
J Pharmacol Exp Ther; 2014 Aug; 350(2):196-204. PubMed ID: 24849924
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of monoacylglycerol lipase reduces nicotine reward in the conditioned place preference test in male mice.
Muldoon PP; Akinola LS; Schlosburg JE; Lichtman AH; Sim-Selley LJ; Mahadevan A; Cravatt BF; Damaj MI
Neuropharmacology; 2020 Oct; 176():108170. PubMed ID: 32479813
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of monoacylglycerol lipase attenuates nonsteroidal anti-inflammatory drug-induced gastric hemorrhages in mice.
Kinsey SG; Nomura DK; O'Neal ST; Long JZ; Mahadevan A; Cravatt BF; Grider JR; Lichtman AH
J Pharmacol Exp Ther; 2011 Sep; 338(3):795-802. PubMed ID: 21659471
[TBL] [Abstract][Full Text] [Related]
30. Monoacylglycerol Lipase Inhibition Prevents Short-Term Mitochondrial Dysfunction and Oxidative Damage in Rat Brain Synaptosomal/Mitochondrial Fractions and Cortical Slices: Role of Cannabinoid Receptors.
Paredes-Ruiz KJ; Chavira-Ramos K; Galvan-Arzate S; Rangel-López E; Karasu Ç; Túnez I; Skalny AV; Ke T; Aschner M; Orozco-Morales M; Colín-González AL; Santamaría A
Neurotox Res; 2023 Dec; 41(6):514-525. PubMed ID: 37458923
[TBL] [Abstract][Full Text] [Related]
31. Comparative biochemical characterization of the monoacylglycerol lipase inhibitor KML29 in brain, spinal cord, liver, spleen, fat and muscle tissue.
Pasquarelli N; Porazik C; Hanselmann J; Weydt P; Ferger B; Witting A
Neuropharmacology; 2015 Apr; 91():148-56. PubMed ID: 25497453
[TBL] [Abstract][Full Text] [Related]
32. The monoacylglycerol lipase inhibitor JZL184 suppresses inflammatory pain in the mouse carrageenan model.
Ghosh S; Wise LE; Chen Y; Gujjar R; Mahadevan A; Cravatt BF; Lichtman AH
Life Sci; 2013 Mar; 92(8-9):498-505. PubMed ID: 22749865
[TBL] [Abstract][Full Text] [Related]
33. Harnessing the Endocannabinoid 2-Arachidonoylglycerol to Lower Intraocular Pressure in a Murine Model.
Miller S; Leishman E; Hu SS; Elghouche A; Daily L; Murataeva N; Bradshaw H; Straiker A
Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3287-96. PubMed ID: 27333182
[TBL] [Abstract][Full Text] [Related]
34. Monoacylglycerol Lipase Inhibitors Reverse Paclitaxel-Induced Nociceptive Behavior and Proinflammatory Markers in a Mouse Model of Chemotherapy-Induced Neuropathy.
Curry ZA; Wilkerson JL; Bagdas D; Kyte SL; Patel N; Donvito G; Mustafa MA; Poklis JL; Niphakis MJ; Hsu KL; Cravatt BF; Gewirtz DA; Damaj MI; Lichtman AH
J Pharmacol Exp Ther; 2018 Jul; 366(1):169-183. PubMed ID: 29540562
[TBL] [Abstract][Full Text] [Related]
35. Neuroprotective Effects of MAGL (Monoacylglycerol Lipase) Inhibitors in Experimental Ischemic Stroke.
Choi SH; Arai AL; Mou Y; Kang B; Yen CC; Hallenbeck J; Silva AC
Stroke; 2018 Mar; 49(3):718-726. PubMed ID: 29440474
[TBL] [Abstract][Full Text] [Related]
36. Monoacylglycerol lipase inhibition blocks chronic stress-induced depressive-like behaviors via activation of mTOR signaling.
Zhong P; Wang W; Pan B; Liu X; Zhang Z; Long JZ; Zhang HT; Cravatt BF; Liu QS
Neuropsychopharmacology; 2014 Jun; 39(7):1763-76. PubMed ID: 24476943
[TBL] [Abstract][Full Text] [Related]
37. Dual inhibition of endocannabinoid catabolic enzymes produces enhanced antiwithdrawal effects in morphine-dependent mice.
Ramesh D; Gamage TF; Vanuytsel T; Owens RA; Abdullah RA; Niphakis MJ; Shea-Donohue T; Cravatt BF; Lichtman AH
Neuropsychopharmacology; 2013 May; 38(6):1039-49. PubMed ID: 23303065
[TBL] [Abstract][Full Text] [Related]
38. The monoacylglycerol lipase inhibitor JZL184 decreases inflammatory response in skeletal muscle contusion in rats.
Jiang SK; Zhang M; Tian ZL; Wang M; Zhao R; Wang LL; Li SS; Liu M; Li JY; Zhang MZ; Guan DW
Eur J Pharmacol; 2015 Aug; 761():1-10. PubMed ID: 25912803
[TBL] [Abstract][Full Text] [Related]
39. Pharmacological inhibition of 2-arachidonoilglycerol hydrolysis enhances memory consolidation in rats through CB2 receptor activation and mTOR signaling modulation.
Ratano P; Petrella C; Forti F; Passeri PP; Morena M; Palmery M; Trezza V; Severini C; Campolongo P
Neuropharmacology; 2018 Aug; 138():210-218. PubMed ID: 29842858
[TBL] [Abstract][Full Text] [Related]
40. Blockade of 2-arachidonoylglycerol hydrolysis produces antidepressant-like effects and enhances adult hippocampal neurogenesis and synaptic plasticity.
Zhang Z; Wang W; Zhong P; Liu SJ; Long JZ; Zhao L; Gao HQ; Cravatt BF; Liu QS
Hippocampus; 2015 Jan; 25(1):16-26. PubMed ID: 25131612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
